Overexpression of Meloe Gene in Melanomas Is Controlled Both by Specific Transcription Factors and Hypomethylation

por Bobinet, Mathilde, Vignard, Virginie, Florenceau, Laetitia, Lang, Francois, Labarriere, Nathalie, Moreau-Aubry, Agnès
Publicado em 2013

PD-1 expression conditions T cell avidity within an antigen-specific repertoire

por Simon, Sylvain, Vignard, Virginie, Florenceau, Laetitia, Dreno, B., Khammari, A., Lang, F., Labarriere, N.
Publicado no Oncoimmunology (2015)

IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens

por Charpentier, Maud, Croyal, Mikael, Carbonnelle, Delphine, Fortun, Agnès, Florenceau, Laetitia, Rabu, Catherine, Krempf, Michel, Labarrière, Nathalie, Lang, François
Publicado no Oncotarget (2016)

The Melanoma Antigens MELOE-1 and MELOE-2 Are Translated from a Bona Fide Polycistronic mRNA Containing Functional IRES Sequences

por Carbonnelle, Delphine, Vignard, Virginie, Sehedic, Delphine, Moreau-Aubry, Agnes, Florenceau, Laetitia, Charpentier, Maud, Mikulits, Wolfgang, Labarriere, Nathalie, Lang, François
Publicado em 2013

Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells

por Rabu, Catherine, Rangan, Laurie, Florenceau, Laetitia, Fortun, Agnès, Charpentier, Maud, Dupré, Emilie, Paolini, Léa, Beauvillain, Céline, Dupel, Estelle, Latouche, Jean-Baptiste, Adotevi, Olivier, Labarrière, Nathalie, Lang, François
Publicado no Oncoimmunology (2019)